S eptic shock is associated with high mortality as a result of complex hemodynamic disturbances, including hypovolemia and arterial abnormal vasodilatation (1, 2) . During sepsis, endothelial dysfunction with impaired release of several endothelium-derived relaxing factors such as prostacyclin, nitric oxide (NO), and endothelium-derived hyperpolarizing factor associated with a release of reactive oxygen species by different pathways contributes to organ failure (3). Data collected from clinical studies and various models of endotoxemia suggest that this phenomenon is related to the activation of the nuclear factor B cell-related family, the NF-B/RelA family, enabling the expression of several specific inflammatory genes (2).
from meta-analyses or the Saline versus Albumin Fluid Evaluation (SAFE) trial (5) for an actual benefit on survival. Nevertheless, the pilot study of Dubois et al (6) suggests that treatment with HSA reduces sequential organ failure assessment score in critically ill patients with hypoalbuminemia. In a previous experimental study (7) , we reported that HSA improved lipopolysaccharide (LPS)induced arterial dysfunction. Among the mechanisms explaining the protective antioxidant effect of HSA, the modulation of cellular glutathione (GSH) as well as transcription of inflammatory genes and apoptosis have been reported (8) .
Prompt restoration of intravascular volume is an early goal in shock resuscitation. The use of crystalloids or colloids for volume replacement in critically ill patients is still debated; however, both fluids are widely used, although they appear to act differentially during shock treatment (9) , especially regarding the use of hyperoncotic albumin, which has been associated with an increased risk of death (10) .
In this context and because the endothelium is a major target of sepsisinduced events and that endothelial cell damage accounts for much of the pathogenesis of septic shock (11) , the present study was designed to assess the mechanisms by which two different concentrations (40 and 200 mg/mL) of HSA might affect endothelial and organ functions as well as survival in both endotoxemic mice and in an endothelial cell model stimulated by a mixture of LPS-tumor necrosis factor-␣ (TNF␣).
MATERIALS AND METHODS

Animals
All animal experimentations were performed in accordance with institutional guidelines and protocols approved by the French Animal Care Committee in keeping with European regulations. Experiments were conducted in compliance with statutory requirements by accredited research scientists. The procedure for the care and euthanasia of studied animals was in accordance with the European Community Standards on the Care and Use of Laboratory Animals (Ministère de l'Agriculture, France, authorization No. 6422 and the regional ethics committee for animal experimentation "CREMEAS").
Male Swiss mice (11) (12) (13) (14) (15) (16) wks old; body weight [bw]: 45-54 g) were used. LPS (from Escherichia coli 055:B5; Sigma Aldrich, Saint Quentin Fallavier, France) was administered by intraperitoneal route at a dose of 50 mg/kg. Control mice received an equivalent volume of vehicle (0.9% NaCl solution) (control group; bw: 47 [43; 50] g). Four and 12 hrs later, mice challenged with LPS were randomized in four groups: mice receiving an infusion of HSA 4%:10 mL/kg or 20%:10 mL/kg (Vialebex, LFB, Paris, France) (HSA 4% group; bw: 51 [46; 54] g and HSA 20% group; bw: 49 [42; 51] g), mice infused with 30 mL/kg of 0.9% saline (NaCl group; bw: 46 [43; 47] g) or no fluid treatment (LPS group; bw: 45 [41; 48] g). Fluid treatment was intravenously infused through the tail vein under light inhaled anesthesia (isoflurane 2%). The survival rate was monitored in each group every 6 hrs after LPS administration. In another set of experiments, mice were bled at hour 4, hour 8, hour 12, and hour 24 for blood sampling. Fifteen hrs after LPS injection, other mice were anesthetized by intraperitoneal injection with a mixture of ketamine (100 mg/kg), medetomidine (50 g/ kg), and heparin (500 U/kg) and then euthanized for ex vivo evaluation of vascular reactivity. The mesenteric resistance arteries (MRAs) were harvested to assess the vascular reactivity and the signaling pathways by Western blot.
Vascular Reactivity
Flow-mediated dilation (FMD) was assessed in MRAs (branches II approximately 200 -230 m diameter). Mesenteric arteries were cannulated at both ends in a videomonitored perfusion system (Living Systems Instrumentation, St Albans, VT). Arteries were bathed in physiological salt solution (pH 7.4, PO 2 160 mm Hg, PCO 2 37 mm Hg). Pressure was controlled by a servoperfusion system and flow was generated by a peristaltic pump. The presence of a functional endothelium was assessed by applying acetylcholine (10 M; Sigma Aldrich, St Quentin Fallavier, France) in arteries precontracted with U46619, a prostaglandin endoperoxide analog that serves as a thromboxane mimetic (1 M; Sigma Aldrich).
To determine FMD at 75 mm Hg of pressure, arteries were contracted with U46619 (50% reduction in diameter of nonreceptor-dependent contraction: KCl 80 mM) and submitted to stepwise increases in intraluminal flow (0 -100 L/min). This was subsequently repeated after addition of N G -nitro-L-arginine methyl ester (100 M; Sigma Aldrich) or after addition of N G -nitro-L-arginine methyl ester with indomethacin (10 M; Sigma Aldrich) to physiological salt solution. At the end of each experiment, to determine the passive diameter of the artery in the absence of smooth muscle tone, arteries were perfused and superfused with Ca 2ϩ -free physiological salt solution containing ethylene glycol tetraacetic acid (2 mM) and sodium nitroprusside (10 M) and diam-eter changes were measured by increasing the luminal pressure from 10 to 125 mm Hg. Pressure and diameter measurements were continuously collected for analysis (Biopac MP 100; BIOPAC Systems, Inc, Goleta, CA).
Western Blot Analysis
The harvested MRAs were quickly frozen and stored at Ϫ80°C. Arterial segments (branches II) were then homogenized with lysis buffer (1% sodium dodecyl sulfate, 10 mmol/L Tris-HCl [pH 7.4], 1 mM sodium orthovanadate, 2.5 mg/L leupeptin, and 5 mg/L aprotinin) (Ultrasonic Processor; Bioblock Scientific, Illkirch, France). Proteins were separated by sodium dodeclysulfate polyacrylamide gel electrophoresis (Mini gel protean II system; Bio-Rad, Marnes-la-Coquette, France; 100 V, with 300 mL of 25 mM Tris, 192 mmol/L glycine, 0.1% sodium dodeclysulfate) using a 4% stacking gel followed by a 9% running gel. After migration, proteins were transferred (100 V, 90 mins, 4°C, with 800 mL of 25 mM Tris, 192 mmol/L glycine, 10% methanol) onto polyvinylidene difluoride blotting membranes (Immobilon-P; Millipore, Molsheim, France). Membranes were then washed in Tris-buffered saline-T buffer (composition: 10 mM Tris-base pH 7.5, 0.1 M NaCl, 1 mM EDTA, 0.1% Tween 20) and blocked for 2 hrs at room temperature with 5% bovine serum albumin in Tris-Buffered Saline Tween-20 (20 mM Tris [pH 8.0], 150 mM NaCl, and 0.1% Tween-20). Membranes were incubated overnight at 4°C with monoclonal murine antiendothelial NO synthase (anti-eNOS), monoclonal anti-eNOS phosphorylated (eNOS Ser 1177 ), monoclonal anti Akt and anti-Akt phosphorylated (Akt Ser 473 ) (BD Biosciences, San Jose, CA), anti-PI 3 -kinase (Santa Cruz Biotechnology, Santa Cruz, CA), monoclonal anti-I-B ␣-phosphorylated (US Biological, Swampscott, MA), Anti-Nrf2 (nuclear respiratory factor) (C-20), (Santa Cruz Biotechnology), anti p67phox (BD Biosciences, San Jose, CA) or antiheme-oxygenase-1 (HO-1) polyclonal antibody (Stressgen Bioreagents, San Diego, CA).
The membranes were then washed at least three times in Tris-buffered solution containing 0.05% Tween and incubated for 1 hr at room temperature with the appropriate horseradish peroxidase-conjugated secondary antibody (Amersham, Piscataway, NJ). The protein-antibody complexes were detected by an ECL enhanced chemiluminescence system (Amersham, Buckingham, UK) and quantified by densitometry according to the protocol recommended by the manufacturer. Quantification of densitometry analyses was expressed as ␤-actin ratio.
Serum Measurements
Blood samples were collected at hour 4, hour 8, hour 12, and hour 24 in the four groups of mice under light inhaled isoflurane anesthesia. Samples were collected by tail vein bleeding using a 4-mm mouse bleeding lancet, and serum levels of albumin, chloride, pH, bicarbonates, and creatinine were measured using a Roche/Hitachi Modular P 800 instrument (Roche Diagnostics, Meylan, France). Serum levels of GSH, oxidized form of GHS: glutathione disulfide (GSSG), and endothelin-1 were measured using colorimetric and enzyme-linked immunosorbent assay kits respectively (Cayman Chemicals, Montluçon, France) with special attention given to laboratory instructions to optimize analysis.
Culture of Human Umbilical Vein Endothelial Cells
Human umbilical vein endothelial cells (HUVECs) were isolated from human umbilical veins as described previously (12) . Cells were cultured in MCDB 131 medium (Invitrogen, Cergy Pontoise, France) containing 2 mM ultraglutamine, 105 U/L penicillin, and 100 mg/L streptomycin supplemented with 10% fetal calf serum (Invitrogen). Cells were used at the second passage. Once HUVECs attained confluence, serum concentration was decreased to 5% for a 12-hr period. Cells were then exposed to the combination of 10 g/mL LPS and 10 nM TNF␣ during 8 hrs (Peprotech, Neuilly-Sur-Seine, France). The effect of HSA (Vialebex, LFB, Paris, France) was studied by adding HSA to cultured cells (middle) at 40 mg/mL or 200 mg/mL to achieve the same concentration as in in vivo experiments (4% and 20%). HUVECs were used to assess NO and superoxide anion (O 2 Ϫ ) production as well as perform GSH and GSSG (Cayman Chemicals, Montluçon, France) measurements and stainings for confocal microscopy.
Electronic Paramagnetic Resonance Studies
NO Spin Trapping. Detection of NO production was performed using a previously described technique with Fe 2ϩ diethyldithiocarbamate (DETC) as a spin trap (13) . Determination of NO formation was assessed by electron spin resonance spectroscopy after formation of [Fe(II)NO(DETC) 2 ], the paramagnetic DETC complex with NO, in HUVECs. Briefly, HUVECs were washed twice with Hank's balanced salt solution buffered with 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid and then incubated in a Hank's balanced salt solution-4-(2-hydroxyethyl)-1piperazineethanesulfonic acid solution in the presence of bovine serum albumin (20 mg/ mL), 1.5 mM CaCl 2 , 0.3 mM L-arginine for 15 mins at 37°C. Spin trap chemicals FeSO 4 (0.8 mM) and DETC (1.6 mM) were separately dissolved under nitrogen gas bubbling in 10-mL volumes of ice-cold Hank's balanced salt solution-4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid buffer. The solutions were rapidly mixed to obtain a pale yellow-brown opalescent colloid [Fe(II)5DETC) 2 ] solution (final concentration 0.2 L), which was used immediately to incubate cells for 45 mins at 37°C. After incubation, the spin trap was removed and cells were scrapped in physiological salt solution and frozen in calibrated tubes in liquid nitrogen for electronic paramagnetic resonance measurements. NO measurement was performed on a tabletop x-band spectrometer Miniscope (MS200; Magnettech, Berlin, Germany). Recordings were made at 77°K using a Dewar flask. Instrument settings were: microwave power, 10 mW; amplitude modulation, 1 mT; modulation frequency, 100 kHz; sweep time, 150 secs; and five scans. Signals were quantified by measuring the total amplitude of the third pick of the spectrum per weight of proteins.
Superoxide Anion (O 2 Ϫ ) Spin-Trapping. HUVECs were incubated in deferoxaminechelated Krebs-4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid solution containing 1 hydroxy-3methoxycarbonyl 2,2,5,5-tetramethylpyrrolidin (5OO M; Noxygen, Elzach, Germany), deferoxamine (25 M, Sigma Aldrich), and DETC (Sigma Aldrich; 5 M) under constant temperature (37°C) for 1 hr. The reaction was stopped by placing the samples in liquid nitrogen (N 2 ) and analyzed in a Dewar flask by the described electronic paramagnetic resonance spectroscopy. The instrument settings were as follows: temperature, 77°K; microwave power, 1 mW; amplitude modulation, 0.5 mT; sweep time, 60 secs; field sweep, 60 G. Values were expressed in signal amplitude/per weight of proteins.
Staining and Imaging by Confocal Microscopy
After staining, cells were analyzed by confocal microscopy. Optical sectioning of cells was achieved using a Nikon Eclipse TE 300 (Nikon, Tokyo, Japan) inverted microscope with a MRC-1024ES scanner. Digital image recordings were performed using the Laser Sharp software; the confocal Assistant software (version 4.0.2) was used for image analysis (TC Brelje, Department of Cell Biology and Neuroanatomy, University of Minnesota, Minneapolis, MN). Results are expressed as a percentage (intensity of the studied sample divided by the intensity of the control sample).
Detection of Superoxide Anion by Dihydroethidium Dye. After three washes with phosphate-buffered saline, cells were incubated with the dihydroethidium dye, which was oxidized by superoxide anion, during 30 mins at 37°C. Cells were then washed three times and immediately analyzed by confocal microscopy with excitation and emission wavelengths of 480 and 586 nm, respectively.
Detection of Peroxynitrite by Nitrotyrosine Staining. After treatment, HUVECs were fixed (with CellFIX; BD Biosciences, Le Pont de Claix, France), washed three times with phosphate-buffered saline, and incubated with a mouse monoclonal antinitrotyrosine (clone 1A6) antibody (1:100; Upstate, Hampshire, UK) at room temperature for 2 hrs. Cells were then washed three times with phosphatebuffered saline and treated with the secondary fluorescence-labeled antibody Alexa Fluor 488 (1:100, Invitrogen Molecular Probes, Leiden, The Netherlands) for 1 hr.. Cell nuclei were stained with propidium iodide (1:1000). Cells were then washed and analyzed by confocal microscopy with excitation and emission wavelengths of 488 and 525 nm for Alexa fluor and 560 and 610 for propidium iodide.
Data Analysis
Two-way analysis of variance for repeated measurements was used for comparison of vascular reactivity (data were tested for homogeneity of variance by Levene's statistics), whereas the nonparametric Kruskal-Wallis test or Mann-Whitney test was used for comparison of mice body weights, GSH, GSSG, endothelin-1, Western blotting, NO, O 2 Ϫ , and immunostaining signal measurements among the five groups. When a significant difference was found between groups, subsequent post hoc tests were performed. Mortality was expressed by the Kaplan-Meier method and compared with the log-rank test. All these tests were performed with the Statview version 5.0 software (SAS Institute, Cary, NC). p Ͻ .05 was considered statistically significant. The effects of acetylcholine were quantified as the percentage of relaxation in preparations previously contracted with U46619. All values of two-way analysis of variance for repeated measurements are presented as mean Ϯ SEM for experiments. Values requiring nonparametric analysis were presented as median with interquartile range with n representing the number of animals.
RESULTS
HSA 4%, But Not HSA 20% or Saline Solution, Improved the Survival Time of Endotoxemic Mice. In terms of body weight, there was no statistical difference between groups. Figure 1 HSA 4%, But Not HSA 20% or Saline Solution, Increased GSH, Decreased GSSG, and Endothelin-1 Serum Levels and Improved Renal Dysfunction Elicited by LPS Challenge. Compared with the control group, LPS induced a significant decrease in GSH concentrations while simultaneously inducing an increase in serum endothelin-1 levels at hour 4, hour 8, hour 12, and hour 24. HSA at 4%, but not at 20%, increased GSH concentrations and significantly decreased the levels of endothelin-1 from hour 4 (p Ͻ .05; Table 1 ). Furthermore, compared with control and LPS groups, HSA at 20% induced high levels of GSSG (p Ͻ .05; Table 1 ). At hour 24, serum albumin concentration, chloride, bicarbonates, pH, and creatinine were measured in all groups (n ϭ 8 for each group of mice). At the time of euthanasia, LPS treatment did not significantly affect native albumin concentrations. Furthermore, the serum albumin level was not modified by saline.
Although the colorimetric quantitative determination of serum albumin did not allow differentiation between murine albumin and HSA, levels of total serum albumin were significantly increased after HSA 4% and 20% treatments (p Ͻ .05; Table 2 ). Furthermore, neither LPS treatment nor saline resuscitation altered chloride concentrations (indirect potentiometry). Thus, the load of saline in the control group did not induce hyperchloremia in our experimental conditions. LPS challenge and HSA at 20% reduced pH and bicarbonate concentration (p Ͻ .05; Table 2 ). Such reduction was not observed after either saline or HSA at 4%. With regard to renal function, LPS, saline, and HSA 20% groups exhibited increased serum creatinine levels compared with controls and HSA 4% groups (p Ͻ .05; Table 2 ).
HSA 4% Decreased LPS-Induced Endothelial Dysfunction in MRA. The stepwise increase in flow induced a signifi-cant dilation in MRAs. Compared with controls, FMD was significantly decreased in the LPS group (p Ͻ .05). HSA at 4%, but not at 20% or saline solution, restored FMD (p Ͻ .05; Fig. 2A ).
In MRA, acetylcholine (100 M) produced endothelial-dependent relaxation. Compared with the control group, LPS significantly decreased the acetylcholinedependent response (p Ͻ .05; Fig. 2B ). The LPS-induced vascular hyporeactivity to acetylcholine was not modified by either HSA 20% or saline, whereas HSA 4% prevented the endothelial dysfunction (p Ͻ .05 compared with the LPS group; Fig. 2B) .
To evaluate the mechanisms by which HSA 4% restores the LPS-induced decreases in FMD, pharmacologic inhibitors were tested in control, LPS, and HSA 4% groups (Fig. 3) . The inhibition of NO synthesis by L-NAME significantly attenuated FMD both in control and HSA 4% groups, whereas N G -nitro-L-arginine methyl ester had no effect on FMD in the LPS group (p Ͻ .05; Fig. 3A ).
Inhibition of both NO and cyclooxygenase pathways did not affect the FMD in the control group; on the other hand, these inhibitors restored the FMD in the LPS group, whereas they induced a 57% decrease in FMD in the HSA 4% group (p Ͻ .05; Fig. 3B ).
HSA 4% Restored eNOS Activation Through Akt/PI 3 Kinase. To investigate the mechanisms involved in the beneficial effect of HSA 4% on endothelialdependent dilation, the role of the eNOS-Akt/phosphoinositide 3-kinase pathway was investigated, because the decrease in this pathway's activity may be attributable to altered eNOS phosphorylation. Compared with the control group, LPS induced a marked decrease in eNOS and in phosphorylated eNOS expression, in Akt and phosphorylated Akt expression as well as in phosphorylated eNOS/eNOS and phosphorylated Akt/Akt ratios, whereas HSA at 4% but not at 20% re-stored this detrimental effect (p Ͻ .05; Fig. 4A and 4B, respectively). Compared with saline and HSA at 20%, the mechanism underlying the activation of eNOS in MRA, in the presence of HSA 4%, remained related to the phosphoinositide 3-kinase/Akt pathway (p Ͻ .05; Fig. 4C ).
HSA 4% Reduced LPS-Induced Upregulation of IB and Inducible NO Synthase and Enhanced the Expression of Nrf-2 and HO-1 Along With a Decrease in p67phox. Inflammation and oxidative stress are largely implicated in endothelial dysfunction. Indeed, during endotoxinic stimulation, IB is phosphorylated, removed, and degraded, allowing free NF-B to induce transcription. Herein, no specific blotting occurred in MRAs harvested from the control group, whereas LPS induced a marked blotting of P-IB and inducible NO synthase. These blottings were decreased in MRAs harvested from the HSA 4%-treated group (Fig. 4D-E) . Similarly, NF-B blotting was decreased in the same group (not shown). Compared with control vessels, LPS induced a significant increase in p67phox expression in MRA. HSA 4% treatment, but not HSA 20% or saline, enhanced Nrf-2 and HO-1 expression, hence significantly preventing the increase in p67phox, whereas HSA 20% decreased HO-1 expression (*p Ͻ .05 vs. control vessels; #p Ͻ .05 vs. LPS vessels; Fig. 4E-G Compared with control endothelial cells, the combination of LPS-TNF␣ induced a higher production of NO in HUVECs. Neither HSA 4% nor HSA 20% treatment modified the LPS-TNF␣-induced increase in NO production (Fig. 5I ). Otherwise, HSA 4% significantly decreased LPS-TNF␣-induced O 2 Ϫ production, whereas HSA 20% tended to increase this production ( Fig. 5J ).
DISCUSSION
We recently reported a protective effect of HSA treatment in mice with endotoxemic shock by the reduction of the inflammatory process leading to oxidative and nitrosative stresses and vascular hyporeactivity (7) . The present study was performed to assess the impact of early HSA treatment on endotoxemic mice survival time and to focus on the mecha-nisms involved in HSA-induced improvements in endothelial dysfunction. The main findings were that HSA increased survival time and reduced endothelial dysfunction in a concentration-dependent manner. This effect was observed with HSA at 4% but not at 20% and was associated with 1) increased eNOS activation in mesenteric resistance arteries through the Akt/phosphoinositide 3-kinase pathway along with a reduced endothelin-1 plasma concentration; 2) enhanced Nrf-2 expression and plasma GSH concentration; and 3) in situ blunting of arterial activation of the transcriptional factor NF-B. Furthermore, both oxidative and nitrosative stresses in endothelial cells were blunted by HSA at 4%, whereas HSA at 20% challenge displayed a potential pro-oxidant effect in our experimental models.
Septic shock is a major healthcare problem, inducing high mortality in intensive care units (14) . Data synthesized from nine randomized controlled trials have demonstrated a clear survival benefit for early and adequate fluid resuscitation in treating early hemodynamic failure during sepsis (15) . However, controversy surrounding the choice of fluid, based on the relative merits and detriments on patient outcome, is still ongoing. Our findings rather support the latest published results of Shortgen et al (10) , who reported a higher mortality rate with hyperoncotic compounds. Indeed, with the available data in our endotoxemic mice model, we show that compared with HSA at 4%, the higher dose of HSA increased p67phox and was associated with a decrease in Nrf-2 expression, a basic leucine zipper redox-sensitive transcriptional factor that plays a key role in antioxidant system-mediated induction of phase II detoxifying and antioxidant enzymes (16) . In addition, the depletion of GSH in serum and HUVECs caused by HSA at 20% challenge, but not observed in the HSA 4% group, was consistently accompanied by an increase in GSSG as well as by reactive oxygen species production in stimulated HUVECs, reflecting that albumin at high concentrations might act as a pro-oxidant in our models. In keeping with this observation, previous studies have shown that the oxidation of GSH to GSSG causes the formation of mixed disulfides between GSSG and cellular protein thiols and that the concentration of intracellular GSSG is as- sociated with their formation (17, 18) . Furthermore, HSA at high concentrations decreased the expression of HO-1, an enzyme enables the removal of the potentially toxic molecules as a lipid-soluble transmissible form of iron (19) and could exhibit pro-oxidant capacities by controlling the redox status of Cys-34-thiol, as also reported for redox properties of copper and redox cycling iron, with negative consequences (20, 21) . Thus, the high concentration of GSSG observed in the present study during HSA 20% challenge may mirror albumin thiol oxidation and potentially result from a high albumin concentration, especially in the context of LPS-induced oxidative and nitrosative stresses (22, 23) . Hence, one could speculate that HSA, at higher doses, may have a decreased antioxidant potential and therefore fails to im-prove LPS-induced renal and endothelial dysfunction.
Endothelial function involves the expression of eNOS, which is increased severalfold by multiple factors, including shear stress and the phosphorylation of eNOS through the Akt/phosphoinositide 3-kinase pathway, which is known to regulate and enhance enzyme activity (24) . Endotoxin challenge involves eNOS activity in the early phase and induces a later increase in inducible NO synthase expression (25, 26) . Thus, LPS impairs endothelium-dependent relaxation to acetylcholine as well as to flow, leading to endothelial dysfunction in both resistance and conductance arteries (27, 28) .
We report in the present study that only HSA at 4%, but not saline or HSA at 20%, overcomes the deleterious endothe-lial effect of LPS on both acetylcholineinduced relaxation and flow-mediated dilation in MRA through the improvement of eNOS activation. Furthermore, the pharmacologic inhibition of NO synthase suggests a role of HSA at 4% on NO regulation, implicating this pathway in its effect. Data from animal models (29, 30) have shown that endotoxemia induces increased expression of inducible NO synthase and a progressive and profound reduction in phosphorylated eNOS expression and thus in eNOS activation. Indeed, our results support such findings because LPS-induced endothelial dysfunction was in part the result of decreased eNOS activity, which is most likely supported by a decrease in Akt phosphorylation in MRAs. Interestingly, HSA 4% treatment improved phosphoinositide 3-kinase expression in MRAs, leading Figure 5 . Human serum albumin (HSA) at 4% but not at 20% protects against lipopolysaccharide (LPS)/tumor necrosis factor ␣ (TNF␣)-induced oxidative and nitrosative stresses in human umbilical vein endothelial cells (HUVECs). Representative histochemical staining for superoxide anion and immunohistochemical staining for nitrotyrosine of HUVECs not exposed (A and E, respectively) or exposed to LPS/TNF␣ (B and F, respectively) and treated with HSA 4% (C and G, respectively) or HSA 20% (D and H, respectively) (n ϭ 6). Green fluorescence is linked to nitrotyrosination and red fluorescence is linked to dihydroethidium dye. Scale bars ϭ 50 m. Quantification of the amplitude of nitric oxide (NO) (I). and superoxide anion (O2-) (J) signal in HUVECs. Values are expressed as median with interquartile range (n ϭ 6). *p Ͻ .05, compared with the control group; #p Ͻ .05, compared with the LPS group.
to phosphorylation of Akt, which, in turn, induced phosphorylation and activation of eNOS, resulting in NO bioavailability and a subsequent increase in MRA relaxation. The simultaneous inhibition of NOS and cyclo-oxygenases exhibited a role for endothelium-derived hyperpolarizing factor in HSS 4%-induced improvement of vascular function. Because endothelium-derived hyperpolarizing factor produces endothelium-dependent hyperpolarization of vascular smooth muscle cells, the combination of proinflammatory mediators could downregulate endothelium-derived hyperpolarizing factor through the induced generation of NO (31) . Previous data (32) have demonstrated that, like in the case of HSA 4% (7) , inhibition of inducible NO synthase restores the hyperpolarizing response to acetylcholine, supporting the hypothesis that, in our model, HSA at 4% but not at 20% acts through a hyperpolarizing pathway.
Furthermore, during sepsis, high concentrations of endothelin-1 may also affect endothelium-dependent hyperpolarization, which may reflect on endothelial dysfunction as well as vasoplegia severity (33, 34) and are likely associated with organ dysfunctions (35, 36) . Conversely, reduction of endothelin-1 concentrations has been reported to improve the outcome of endotoxemic animals (37, 38) . Thus, in the present study, the reduction in endothelin-1 serum levels by HSA 4% may reflect a protective effect on endotoxin-induced vascular dysfunction.
Endotoxins also induce systemic and arterial inflammations by activating cytokine networks (27, 39) and endothelial dysfunction has been associated with number of pathophysiological processes (11) . Thus, inflammation associated with oxidative stress appears to be a common pathway underlying endothelial cell disturbance.
Several evidences (40) suggest that O 2 Ϫ , NO, and peroxynitrite overproductions, which mirror oxidative and/or nitrosative stresses, play a consistent role in the vascular dysfunction of sepsis. These products exacerbate the course of inflammation through activation of redox-sensitive transcription of proinflammatory factors such as NF-B (41), resulting in increased production of cytokines, recruitment of neutrophils, and modification of various systemic and vascular expression of proteins (1) . In the present study, we show that HSA 4% enhanced Nrf-2 and HO-1 expression, which are implicated in cytoprotective and adaptive responses to various cell damages (19, 42, 43) . Indeed, Nrf-2 participates in the decrease in p67phox protein and P-IB expression and potentially in subsequent oxidative and nitrosative stresses through antioxidant system-mediated induction (by increasing GSH serum levels). Thus, we showed that HSA at 4% decreased O 2
Ϫ levels in stimulated HUVECs and it could be suggested that HSA 4% may also contribute in protecting cells against oxidant-mediated injury through activation of the oxidant-sensitive transcription of proinflammatory proteins (16) . Although albumin is an extracellular molecule, most cell types take it up; catabolism of albumin could therefore potentially represent a source of sulfur-containing amino acids for cells in the synthesis of thiol-containing molecules such as GSH (8, 44) . Because antioxidants are considered a rational target in the treatment of sepsis-induced microcirculatory disturbances (45) , it could be speculated that HSA at 4% induces a blockade of these oxygen and nitrogen species featured by potent proapoptotic and proinflammatory effects (46, 47) and may thereby constitute a beneficial protective treatment. Thus, as we previously reported (7) , HSA 4% attenuates LPS-induced arterial dysfunction with at least a partial beneficial effect on endothelial dysfunction. Because in stimulated HUVECs, HSA 4% did not alter the concentration of NO, the thiol may become S-nitrosated, and S-nitrosoalbumin may constitute a reservoir of NO (48) and hence contribute to the improvement of endothelial function. Indeed, although inducible NO synthase induces a release of large quantities of NO and is implicated in vasodilation of sepsis, it is conceivable that a critical residual fraction of this NO is required for vital organ perfusion and blood vessel potency according to the Cuzzocrea et al hypothesis (49) . NO is thus one of the major endothelial relaxant factors, allowing endothelium to regulate smooth muscle tone and proliferation, leukocyte recruitment, and platelet aggregation (50) .
Study Limitations. Our study has several limitations. Indeed, we have used endotoxin instead of bacterially induced septic shock for practical reasons, because it is especially difficult to standardize a bacterial sepsis and particularly the well-accepted fecal peritonitis. In addition, fluid resuscitation was not titrated on hemodynamic targets as is commonly performed in clinical practice. The higher HSA concentration may have overchallenged the animals from a fluid standpoint with putative detrimental effects on lungs and subsequent increased inflammation. Finally, we did not perform a dose-response curve to assess the optimal concentration of HSA. However, the present results nevertheless confirm the double-edged nature of antioxidant therapies.
CONCLUSIONS
The current study demonstrates that HSA at 4%, but not at 20%, increased survival during endotoxemia-induced mortality by improving organ functions such as endothelial function. When administered at adequate dose, HSA plays a key role in the regulation of LPS-induced oxidative stress as well as GSH and endothelin-1 plasma levels, implying antiinflammatory and antioxidant properties. Our data therefore suggest a potential use of HSA at usual doses in septic shock not only for fluid challenge, but also as specific treatment of endothelial dysfunction. Conversely, higher concentrations of HSA were detrimental suggesting a dose-dependent effect.
